Concord Biotech Shareholding

Concord Biotech Ltd Shareholding Pattern

The Concord Biotech Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Concord Biotech Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Concord Biotech Ltd (NSE: CONCORDBIO, BSE: 543960) operates in the Commercial services sector and Miscellaneous commercial services industry. Monitoring the Concord Biotech Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Concord Biotech Ltd Shareholding Pattern (Latest)

The latest Concord Biotech Ltd shareholding for Dec 2025 is:

• Promoters: 44.08%
• FII: 7.58%
• DII: 9.58%
• Public: 38.76%
• Government: 0%

Promoter holding in Concord Biotech Ltd remains stable, reflecting consistent long-term commitment.

Concord Biotech Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Concord Biotech Ltd.

• Dec 2025: 44.08%
• Sept 2025: 44.08%
• Jun 2025: 44.08%
• Mar 2025: 44.08%
• Dec 2024: 44.08%

Promoter stake remains largely stable, showing consistent ownership structure.

Concord Biotech Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Concord Biotech Ltd.

• Dec 2025: 7.58%
• Sept 2025: 8.03%
• Jun 2025: 9.11%
• Mar 2025: 9.35%
• Dec 2024: 8.33%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Concord Biotech Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 9.58%
• Sept 2025: 9.55%
• Jun 2025: 8.87%
• Mar 2025: 9.16%
• Dec 2024: 9.66%

DII stake in Concord Biotech Ltd has increased over time, indicating growing domestic institutional confidence.

Concord Biotech Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 38.76%
• Sept 2025: 38.33%
• Jun 2025: 37.95%
• Mar 2025: 37.41%
• Dec 2024: 37.93%

Public participation in Concord Biotech Ltd has increased, indicating rising retail investor interest.

Concord Biotech Ltd Government Holding

Government holding in Concord Biotech Ltd currently stands at 0%.

Concord Biotech Ltd operates without significant government ownership.

Concord Biotech Ltd Shareholding Analysis Summary

The Concord Biotech Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Concord Biotech Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Concord Biotech Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.